ArticleOman medical journal2024
Postpartum Hemorrhage Following Vaginal and Cesarean Section Deliveries at a Single Tertiary Hospital: A Five-year Cross-sectional Study.
Article in Oman medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Article
- Predictors of Postpartum Hemorrhage Following Repeat Cesarean Section: A Retrospective Cohort Study.Cureus · 2026Article
- Article
- Profile of severe maternal morbidity cases by nationality in Colombia: analysis of national surveillance data, 2021.Frontiers in global women's health · 2026Article
- Incidence and Risk Factors of Postpartum Hemorrhage in Cesarean Versus Vaginal Deliveries: A Retrospective Study.Cureus · 2025Article
- Postpartum hemorrhage following vaginal delivery and associated risk factors in the United Arab Emirates: The Mutaba'ah study.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to examine the prevalence, etiology, management, and outcomes of postpartum hemorrhage (PPH) following vaginal and cesarean delivery. Methods: We conducted a cross-sectional study on women who delivered at Sultan Qaboos University Hospital from January 2017 to December 2021 and experienced PPH. PPH was defined as per World Health Organization criteria of blood loss > 500 mL after vaginal delivery and 1000 mL after cesarean delivery. The study evaluated demographic parameters, pre-delivery and discharge hemoglobin, estimated blood loss, etiology, pharmacological, mechanical, and surgical interventions for PPH, and the need for blood products. Results: There were 18 136 vaginal deliveries, of which 729 women had PPH, with a prevalence of 4.0%. Among 2771 cesarean sections, 360 women had PPH, with a prevalence of 13.0%. Hemoglobin < 11 g/dL was found in 278 (38.1%) and 140 (38.9%) women before vaginal delivery and cesarean section, respectively. Grand multiparas had the highest prevalence of PPH after vaginal delivery (42.7%). In cesarean deliveries, the majority (48.6%) were women with parity 2-4. Poor uterine tone was the cause of PPH in 616 (84.5%) vaginal deliveries and 263 (73.1%) cesarean deliveries. Surgical interventions were required in 244 (33.5%) women after vaginal delivery and 82 (22.8%) women after cesarean section. The average blood loss was 860 mL after vaginal delivery and 1400 mL after cesarean section. Blood transfusion was required in 74 (10.2%) women after vaginal delivery and 127 (35.3%) women after cesarean section. There was one maternal mortality due to atonic PPH after vaginal delivery. Conclusions: Active management of the third stage of labor and repeated emergency obstetric drills have reduced adverse outcomes. Addressing anemia in pregnancy and further research on carbetocin use in cesarean sections are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.